NIRA Skin

Dermatology at Home

NIRA Skin

Dermatology at Home

Peabody, MA
Consumer Products
Health Tech
Dermal Photonics’ affordable skincare laser noticeably reduces fine lines and wrinkles around the eyes with only 1-2 minutes of daily usage, all in the comfort of your own home. Dermal Photonics' system is the first of its kind, delivering dramatic and lasting improvements by stimulating natural collagen production to renew skin without causing pain or redness. Dermal Photonics is FDA Cleared with proven safety and efficacy based on clinical studies that were reviewed and cleared by the US government.

$31,453

raised
33
Investors
79
Days Left
$1.06
Price per Share
$16M
Valuation
Equity
Offering Type
$244.86
Min. Investment

$31,453

raised
33
Investors
79
Days Left
$1.06
Price per Share
$16M
Valuation
Equity
Offering Type
$244.86
Min. Investment

Bonus Rewards

Get rewarded for investing more into NIRA Skin

$500+
Investment
First Volume Perk
Invest $500+ Receive a 35% discount coupon for NIRA Skincare Laser & Serum bundle ($157 retail value)
$1,000+
Investment
Second Volume Perk
Invest $1,000+ Receive a 50% discount coupon for NIRA Skincare Laser & Serum bundle ($225 retail value)
$2,500+
Investment
Third Volume Tier
Invest $2,500+ Recieve a free NIRA Skincare Laser & Serum bundle ($450 retail value)
$10,000+
Investment
Fourth Volume Tier
Invest $10,000+ Recieve a NIRA Skincare Laser autographed by inventor and company founder

Reasons to Invest

Great Product - Our FDA cleared technology delivers dramatic and lasting wrinkle reduction without side effects and is protected by over 10 patents
Experienced Team - Company founder is a seasoned entrepreneur who developed successful laser technologies for professional medical, surgical, military, and telecom systems
Large Market - The $100B skincare market is ripe for disruption and with strong indicators from our clinical study, we are in a great position to become a market leader

“Naturally renew your skin at home with the same laser technology as dermatologists.”

Dermal Photonics' products are clinically proven to reduce wrinkles and fine lines around the eyes and provide lasting results without the negative side effects often associated with laser skincare technology.

Skin problems are expensive and often challenging to fix

Most home skin care lasers on the market cost $500 or more (such as Tria Beauty, Iluminage Laser, ReAura Laser, Palovia, and more) and cause pain and redness. Many LED systems are not even FDA approved or proven to deliver lasting results. Similar products for wrinkle reduction like microcurrent devices require users to apply an uncomfortable sticky cream in order to be effective. The anti-aging market is still dominated by topical creams and serums which do not penetrate deep into the dermal skin layers like the laser and therefore do not provide true long term effects.   [Market References: www.grandviewresearch.com/industry-analysis/skin-care-products-market]

Safe and effective advanced anti-aging technology at a low cost

Dermal Photonics' first product, the NIRA skincare laser, is clinically proven to significantly reduce fine lines and wrinkles within 2-3 months, with daily treatments of  just 1-2 minute! Key results from the clinical study are as follows:

  • 99% of users found the NIRA Laser easy to use

  • 87% of Users enjoyed the treatment 

  • 89% of Users added the treatment to their daily routine

  • 93% of Users felt the results of treatment met or exceeded their expectations

[Based on company's clinical results as submitted to the FDA for all percentages above and in chart]

Our next products to hit the market are planned to be an acne laser and a full-face skin renewing laser. See preliminary acne results below. Later, the company plans to launch laser products to gently treat other skin concerns such as psoriasis, age spots, warts, mollescum, and foot fungus, all without painful or negative side effects.

Demand for a solution is at an all-time high

The worldwide market for anti-aging products (both devices and topicals) is about $40 billion and the worldwide market for acne products is about $8 billion. Dermal Photonics' laser products will fully address both markets and we plan to launch complementary topical products to be used together with the lasers, allowing the company to generate recurring revenue. [Market References: www.grandviewresearch.com/industry-analysis/skin-care-products-market , www.alliedmarketresearch.com/acne-medication-market]

The media loves Dermal Photonics!

Our product has been featured in Star magazine and Life & Style Weekly, as well as on ABC Boston News affiliate WCVB, ABC Chicago affiliate Windy City Live, and Coffee with America. Ideal World home shopping network featured Dermal Photonics in the United Kingdom and sold out of product within its first airing and subsequently ordered 200% additional stock to cover the remaining shows for the week. QVC in the USA will begin airing live shows for Dermal Photonics in Q1 2020.

Dermal Photonics' skincare laser for fine lines and wrinkles was FDA approved in 2017. Since then, we optimized the design and production to make our product as reliable, high quality and cost effective as possible. In March of 2019, we began volume production followed by our mass-market commercial launch in September of 2019. 

Technology engineered to be gentle and effective for all skin-types

The Dermal Photonics laser uses patented P3 technology to reduce wrinkles and fine lines by gently heating the cells in your skin’s dermis layer. The light from the laser causes the cells to release proteins which signals the body to rejuvenate and renew the dermal area.

Dermal Photonics further developed a nature Hyaluronic Acid Advanced Serum to compliment the laser treatments. The serum is made of 99% all-natural ingredients formulated for all skin-types and is a best-in-class moisturizer. Initial sales of serum are favorable and may lead to a recurring line of topicals with recurring revenue. 

High profits, low costs, and great quality!

It costs us about $39 to make one laser and about $3 to make the serum.  We sell the product through distribution for between $100 to $199, depending on the channel and volumes. We also sell directly through digital marketing, social media and our website for our full retail price of $399.  In all channels, we have excellent margins, as we have a highly profitable business model.  

Affordable and dramatic results without all the hassle

In our experience, other companies offering home laser systems have been introduced to the market, but none have made a mass-market impact because they were overpriced ($500+) and have had adverse side-effects including pain and redness. We've seen many of these companies since withdraw their products or go bankrupt.  Competitive low-end technologies like LED systems are not FDA cleared and proven to give actual results, and they have not caught on either. 

At Dermal Photonics, we offer real and dramatic results using best-in-class technology (lasers) while avoiding all the traditional issues with lasers - high cost, pain, redness (erythema), and difficulty of use.

Dermal Photonics goal is to become the go-to anti-aging and skin-improvement company on the market

Within 5 years, we believe Dermal Photonics will be the leading skincare company with successful products in anti-aging and acne. Once we establish Dermal Photonics as a leader in the space, we plan to launch a 3rd product line for other major multi-billion-dollar skin ailments. Our goal as a company is to be the go-to device for skincare concerns.  

Experts in the industry

Founder, David Bean, has worked in the laser market for over 20 years and in the dermatology laser market for over 15 years.  Mr. Bean developed the core semiconductor laser chip for his first company, SemiNex Corp, which he continues to manage.  SemiNex is now the market leader for semiconductor lasers, used by the medical profession, military, telecommunications testing, and surgical markets.  

David Beans’ knowledge of the medical market enabled him to develop not only the best laser diodes, but also the P3 laser treatment technology which includes all the benefits of laser technology without the harsh side effects. His prior experience with overseeing high-volume factory production  at low costs will also help Dermal Photonics as the company grows and expands the products it offers.

The best product on the market, plus an expert marketing team!

Our product works. And not only that, but it does so safely and at a price that almost anyone can afford. The aging and skincare market is woefully underserved and there is a high demand for better products. We believe that our low cost position, as well as our expert team of marketing and engineering professionals, provide us with an incredible opportunity for rapid growth and excellent margins. Click below for the ABC News report on the company for more details.

In the Press

WCVB
January 1, 2017

Cutting-edge skincare laser promises wrinkle reduction

Coffee with America
January 1, 2017

Do you look in the mirror each morning and wish you could do something about those fine lines and wrinkles? NIRA may be just what you are looking for... In just 2 minutes a day NIRA renews your skin with its patented laser technology that stimulates your skin to build new collagen.

Ideal World Home Shopping TV
January 1, 2017

Ideal World hosts the TV launch of NIRA Skin with interviews with founder and investor, demonstrations, explanations of the technology and more.

Offering Summary


Company

:

Dermal Photonics Corporation

Corporate Address

:

100 Corporate Place, Ste 303, Peabody, MA 01960

Offering Minimum

:

$9,998.98

Offering Maximum

:

$106,999.58

Minimum Investment Amount

(per investor)

:

$244.86











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

9,433

Maximum Number of Shares Offered

:

100,943

Price per Share

:

$1.06

Pre-Money Valuation

:

$15,980,035.30











*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below

Time-Based Perks*:

Super Early Bird:

Invest $500+ within 48 hours and receive $500 worth of product. Includes a NIRA laser + 2 Hyaluronic Acid Advanced Serums (4 months of serum) 

*This bonus supercedes perks/bonuses associated with investments under $10,000

Early Bird:

Invest $500+ within the first 7 days and receive $450 worth of product. Includes a NIRA laser + 1 Hyaluronic Acid Advanced Serum (2 months of serum) 

*This bonus supercedes perks/bonuses associated with investments under $10,000

Amount Based Perks*: 

For the amounts invested below, you will recieve the associated bonus.

Invest $500+ 

Receive a 35% discount coupon for NIRA Skincare Laser & Serum bundle ($157 retail value)

Invest $1,000+

Receive a 50% discount coupon for NIRA Skincare Laser & Serum bundle ($225 retail value)

Invest $2,500+

Recieve a free NIRA Skincare Laser & Serum bundle ($450 retail value)

Invest $10,000+

Recieve a NIRA Skincare Laser autographed by inventor and company founder

*All perks occur after the offering is completed.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Any expense labeled “Travel and Entertainment”.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$1,171,976.00 USD
$293,670.00 USD
Cash And Cash Equivalents
$726,049.00 USD
$13,963.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$218,659.00 USD
$119,627.00 USD
Long Term Debt
$500,000.00 USD
$0.00 USD
Revenues And Sales
$2,388.00 USD
$25,475.00 USD
Costs Of Goods Sold
$56,845.00 USD
$2,233.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$335,730.00 USD
-$237,396.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Follow NIRA Skin to get notified of future updates!

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}